The phrase "analyzed in a relapsed" is not correct and does not make sense in written English.
It seems to be an attempt to convey a concept related to analysis and relapse, but the wording is unclear and likely incorrect.
Example: "The data was analyzed in a relapsed state, revealing patterns of behavior that were previously unnoticed."
Alternatives: "analyzed during a relapse" or "examined in a relapsed condition".
The influence of age, Karnofsky performance status (KPS), tumor burden, pretreatment with temozolomide (TMZ), type of surgery for initial diagnosis and number of previous relapses on outcome was analyzed in a proportional hazards regression model.
To compare the consistency of the methylation degrees before and after treatment, the promoter methylation has been analyzed in 17 primary tumors and relapses of the same patients.
The Date of Relapse field we analyzed in this study had overloaded the NULL value, which could mean either that there was no date of relapse (i.e. the cancer had not relapsed) or that the date of relapse was not known (e.g. there was information that the cancer had relapsed, but the exact date when the relapse was diagnosed could not be established).
To determine the independence of baseline aromatase expression as a prognostic marker in our established multivariable models based on the post-treatment surgical sample, the baseline aromatase status was analyzed in the context of the preoperative endocrine relapse index (PEPI) (Table 4) [ 14].
Relapse patterns were analyzed in several studies previously.
Disease-free survival (DFS) was measured the same way, according to the presence of locoregional or systemic relapse, and was only analyzed in patients without metastases (M0 patients).
Data from a systematic review performed by NICE were used, due to the lack of head-to-head trials between the drugs analyzed, although differences in relapse definition over the 17 studies included in this meta-analysis could lead to different relapse rates and potentially influence results.
Liu and colleagues [ 15] analyzed predictors of late relapse in early-stage ER-positive breast cancer, in which differences in the primary tumor tissue in patients with distant relapses occurring early (less than 3 years) versus late (after 7 years) have been compared.
Despite no statistically difference among HIV status in the relapse group, probably due to the few number analyzed, there was a trend to an increase of relapse in HIV negative.
Aziridinylbenzoquinone (AZQ) therapy induced a complete response in a patient who relapsed during VP-16 therapy.
